Up to 95% of CF individuals not treated with CFTR potentiators and modulators, struggle with respiratory failure due to chronic bacterial infections accompanied by airway inflammation (Lyczak et al., 2002; Schaupp et al., 2023). Here, CFTR is linked to cystic fibrosis.